Currently, a sizable proportion of semaglutide users remain at a sub-maintenance dose [20]
Many candidates are midlife women, and roughly 70% of women experience weight gain during menopause, so overlapping perimenopausal hormone changes commonly complicate symptom attribution during GLP-1 treatment
Maintaining access to care helps lower the number of medical problems residents face
Patients are advised to take it on an empty stomach with a small amount of water, waiting at least 30 minutes before eating or taking other medications
Maximum efficacy requires a minimum of 90 days of use, applied at least twice per day
Special Populations and Dosage Considerations The diverse spectrum of patient populations means that specific groups, such as pregnant women, the elderly, children, or individuals with certain underlying conditions, may not be candidates for GLP-1 therapy or may necessitate special dosage considerations